OTC Markets OTCQX - Delayed Quote USD

Covalon Technologies Ltd. (CVALF)

2.2100

-0.0800

(-3.49%)

At close: January 10 at 3:56:12 PM EST

Covalon Technologies Ltd.'s (CVE:COV) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

With its stock down 12% over the past month, it is easy to disregard Covalon Technologies (CVE:COV). However, stock...

Simply Wall St. 3 days ago

CVALF
-3.49%
Covalon Announces Strong Fourth Quarter and Year End Fiscal 2024 Results

MISSISSAUGA, Ontario, January 07, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 fourth quarter and year end results for the period ended September 30, 2024.

Business Wire 4 days ago

CVALF
-3.49%
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2024 Financial Results

MISSISSAUGA, Ontario, December 19, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2024 financial results on Tuesday, January 7, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Tuesday, January 7, 2025, at 8:30am ET.

Business Wire 23 days ago

CVALF
-3.49%
Investors in Covalon Technologies (CVE:COV) have seen strong returns of 200% over the past year

When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right stock...

Simply Wall St. 2 months ago

CVALF
-3.49%
Covalon Technologies Highlights Compassionate Care Technologies at 2024 ANCC National Magnet Conference

MISSISSAUGA, Ontario, October 30, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), is pleased to announce its participation in the American Nurses Credentialing Center ("ANCC") National Magnet Conference® from Wednesday, October 30 to Saturday, November 1, 2024, in New Orleans, LA.

Business Wire 2 months ago

CVALF
-3.49%
Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting

MISSISSAUGA, Ontario, September 27, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), is pleased to announce its participation in the 2024 Association for Vascular Access ("AVA") Annual Scientific Meeting. The event will take place from September 28 to 30 in Colorado. Founded in 1985, AVA’s multidisciplinary membership is dedicated to advancing research, providing education, and fostering collaboration to improve patient outcomes in vascular access. Covalon

Business Wire 3 months ago

CVALF
-3.49%
Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver

VANCOUVER, BC / ACCESSWIRE / September 24, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VANCOUVER taking place on September 25-26, 2024, where 50 MicroCap public and private companies will be presenting at the Fairmont Waterfront ...

ACCESSWIRE 3 months ago

SSLCF

GHIFF

NWVCF
Covalon Announces Successful Warrant Redemption from 2019 Private Placement

MISSISSAUGA, Ontario, September 23, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce that the directors of the Company (the "Insiders") have exercised a cumulative total of 852,700 common share purchase warrants ("warrants"), generating proceeds of approximately $1.7 million CAD. In addition to the Insiders, long-term shareholders exercised 1,875,800 warrants, generating proceeds of approximat

Business Wire 3 months ago

CVALF
-3.49%
Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST

MISSISSAUGA, ON / ACCESSWIRE / September 19, 2024 / Covalon Technologies Ltd., ("Covalon"), (TSXV:COV)(OTCQX:CVALF), an advanced medical technologies company, today announced that it will be presenting and participating in meetings at the Planet MicroCap ...

ACCESSWIRE 3 months ago

CVALF
-3.49%
Covalon Technologies Ltd. to Showcase Innovative Vascular Access Solutions at the Annual Association of Pediatric Hematology/Oncology Nurses Conference

MISSISSAUGA, Ontario, September 11, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the Association of Pediatric Hematology/Oncology Nurses (APHON) Annual 2024 Conference. The conference, taking place in Salt Lake City, Utah from September 11 to 13, is a premier event for pediatric hematology/oncology nursing professionals involved in patient care, education, case management, an

Business Wire 3 months ago

CVALF
-3.49%
Covalon Announces Strong Third Quarter Fiscal 2024 Results

MISSISSAUGA, Ontario, August 21, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 third quarter results for the period ended June 30, 2024.

Business Wire 4 months ago

CVALF
-3.49%
We Think Covalon Technologies (CVE:COV) Can Easily Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Simply Wall St. 4 months ago

CVALF
-3.49%
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2024 Financial Results

MISSISSAUGA, Ontario, August 14, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2024 financial results on Wednesday, August 21, 2024, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, August 21, 2024, at 8:30am ET.

Business Wire 4 months ago

CVALF
-3.49%
Covalon Technologies Second Quarter 2024 Earnings: EPS: CA$0.06 (vs CA$0.028 loss in 2Q 2023)

Covalon Technologies ( CVE:COV ) Second Quarter 2024 Results Key Financial Results Revenue: CA$8.41m (up 16% from 2Q...

Simply Wall St. 7 months ago

CVALF
-3.49%
Covalon Announces Profitable Second Quarter Fiscal 2024 Results

MISSISSAUGA, Ontario, May 29, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 second quarter results for the period ended March 31, 2024.

Business Wire 7 months ago

CVALF
-3.49%
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2024 Financial Results

MISSISSAUGA, Ontario, May 22, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2024 financial results on Wednesday, May 29, 2024, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, May 29, 2024, at 8:15am ET.

Business Wire 7 months ago

CVALF
-3.49%
Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO

MISSISSAUGA, Ontario, May 17, 2024--INS 2024 Meeting attendees are invited to explore Covalon’s innovative vascular access products first-hand.

Business Wire 7 months ago

CVALF
-3.49%
Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders

MISSISSAUGA, Ontario, March 07, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the matters voted upon at its Fiscal 2023 Annual Meeting of Shareholders ("AGM") held March 6, 2024.

Business Wire 10 months ago

CVALF
-3.49%
Covalon Announces First Quarter Fiscal 2024 Results

MISSISSAUGA, Ontario, February 28, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 first quarter results for the period ended December 31, 2023.

Business Wire 10 months ago

CVALF
-3.49%
Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024

MISSISSAUGA, Ontario, February 28, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 6, 2024 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting will include a presentation from Covalon’s recently appointed CEO, Brent Ashton, with

Business Wire 10 months ago

CVALF
-3.49%

Performance Overview

Return	CVALF	S&P/TSX Composite index
YTD	-1.78%	+0.60%
1-Year	+160.00%	+18.10%
3-Year	+19.46%	+17.47%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Covalon Technologies Ltd. (CVALF)

Covalon Technologies Ltd.'s (CVE:COV) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Covalon Announces Strong Fourth Quarter and Year End Fiscal 2024 Results

Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2024 Financial Results

Investors in Covalon Technologies (CVE:COV) have seen strong returns of 200% over the past year

Covalon Technologies Highlights Compassionate Care Technologies at 2024 ANCC National Magnet Conference

Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting

Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver

Covalon Announces Successful Warrant Redemption from 2019 Private Placement

Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST

Covalon Technologies Ltd. to Showcase Innovative Vascular Access Solutions at the Annual Association of Pediatric Hematology/Oncology Nurses Conference

Covalon Announces Strong Third Quarter Fiscal 2024 Results

We Think Covalon Technologies (CVE:COV) Can Easily Afford To Drive Business Growth

Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2024 Financial Results

Covalon Technologies Second Quarter 2024 Earnings: EPS: CA$0.06 (vs CA$0.028 loss in 2Q 2023)

Covalon Announces Profitable Second Quarter Fiscal 2024 Results

Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2024 Financial Results

Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO

Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders

Covalon Announces First Quarter Fiscal 2024 Results

Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024

Performance Overview